Diane Harper
Dartmouth College, USA

Diane Harper is a Professor in the Department of Obstetrics/Gynaecology and Community and Family Medicine at Dartmouth Medical School in Hanover, New Hampshire, USA, and also serves in the Women’s and Gender Studies Department of Dartmouth College. She is the Director of the Gynaecologic Cancer Prevention Research Group at the Norris Cotton Cancer Centre in Lebanon, New Hampshire, part of the Dartmouth Hitchcock Medical Centre (DHMC), in which work on all aspects of HPV associated diseases, specifically cervical cancer prevention, is conducted. After graduating in chemical engineering and polymerics from Massachusetts Institute of Technology, Professor Harper received her medical degree from the University of Kansas in Kansas City, where she also did residencies in OB/GYN and Family Medicine. Since 1990, Professor Harper has been a local director of the CDC’s Breast and Cervical Cancer Early Detection Program, serving at the state level both in Missouri and in New Hampshire. She has served as a Board Member of the National Home Office Advisory Group on Cervical Cancer. She participated in the three national guideline meetings to discuss the implications of HPV on women’s cervical health; these meetings determined the future nomenclature of cytology, screening conditions, and management of abnormal cytology, and histology reports. Professor Harper’s research interests include women’s and men’s health issues with specific emphasis on prevention, screening, immunology, early diagnosis, and treatment of HPV-associated diseases, and communicating about these areas.

Biography Updated on 26 February 2008

Personal Home Page

http://www.hpvresource.org/doctor.php?facultyID=10

Articles in Scholarly Journals [Incomplete List]

  1. Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines
    Clinical and Vaccine Immunology, vol. 14, no. 6, pp. 792–795, 2007
  2. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
    New England Journal of Medicine, vol. 356, no. 19, pp. 1928–1943, 2007
  3. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
    The Lancet, vol. 369, no. 9580, pp. 2161–2170, 2007
  4. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
    The Lancet, vol. 369, no. 9574, pp. 1693–1702, 2007
  5. The Effect of Oral Contraceptives on Bone Mass and Stress Fractures in Female Runners
    Medicine & Science in Sports & Exercise, vol. 39, no. 9, pp. 1464–1473, 2007
  6. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    The Lancet, vol. 367, no. 9518, pp. 1247–1255, 2006
  7. Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
    CancerSpectrum Knowledge Environment, vol. 98, no. 2, pp. 92–100, 2006
  8. Prevention strategies of cervical cancer in the HPV vaccine era
    Gynecologic Oncology, vol. 103, no. 1, pp. 21–24, 2006
  9. Chapter 13: Current findings from prophylactic HPV vaccine trials
    Vaccine, vol. 24, pp. S114–S121, 2006
  10. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
    Vaccine, vol. 24, no. 27-28, pp. 5571–5583, 2006
  11. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
    Vaccine, vol. 23, no. 17-18, pp. 2388–2394, 2005
  12. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
    The Lancet Oncology, vol. 6, no. 5, pp. 271–278, 2005
  13. How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts
    International Journal of STD & AIDS, vol. 16, no. 3, pp. 203–211, 2005
  14. Clinical Question: Ask the Experts
    Journal of Lower Genital Tract Disease, vol. 8, no. 1, pp. 78–79, 2004
  15. Beyond the Pap: Assessing Patients' Priorities for the Annual Examination
    Journal of Women's Health, vol. 13, no. 7, pp. 791–799, 2004
  16. Magnification and Chromoscopy with the Acetic Acid Test
    Endoscopy, vol. 36, no. 8, pp. 748–750, 2004
  17. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    The Lancet, vol. 364, no. 9447, pp. 1757–1765, 2004
  18. Review: several non-pharmacological, pharmacological, and surgical treatments may be effective in urinary incontinence
    Evidence-Based Medicine, vol. 9, no. 6, pp. 173–173, 2004
  19. Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study☆
    American Journal of Obstetrics and Gynecology, vol. 190, no. 5, pp. 1249–1257, 2004
  20. Factors Affecting the Detection Rate of Human Papillomavirus
    The Annals of Family Medicine, vol. 1, no. 4, pp. 221–227, 2003
  21. Tampon Samplings With Longer Cervicovaginal Cell Exposures Are Equivalent to Two Consecutive Swabs for the Detection of High-Risk Human Papillomavirus
    Sexually Transmitted Diseases, vol. 29, no. 11, pp. 628–636, 2002
  22. Randomized clinical trial of PCR–determined human papillomavirus detection methods: Self-sampling versus clinician-directed–Biologic concordance and women's preferences
    American Journal of Obstetrics and Gynecology, vol. 186, no. 3, pp. 365–373, 2002
  23. Analysis of acetic acid-induced whitening of high-grade squamous intraepithelial lesions
    Journal of Biomedical Optics, vol. 6, no. 4, p. 397, 2001
  24. Self-reported desire to improve colposcopic impressions
    Archives of Gynecology and Obstetrics, vol. 264, no. 3, pp. 137–142, 2000
  25. Treatment threshold probability for vaginitis
    American Journal of Obstetrics and Gynecology, vol. 183, no. 2, pp. 517–518, 2000
  26. Home Study Course: Summer 2000
    Journal of Lower Genital Tract Disease, vol. 4, no. 3, pp. 175–178, 2000
  27. Image analysis for discrimination of cervical neoplasia
    Journal of Biomedical Optics, vol. 5, no. 1, p. 72, 2000
  28. Leukocytes in the Cervix: A Quantitative Evaluation of Cervicitis
    Obstetrics & Gynecology, vol. 91, no. 6, pp. 987–992, 1998
  29. Prenatal predictors of cesarean section due to labor arrest
    Archives of Gynecology and Obstetrics, vol. 256, no. 2, pp. 67–74, 1995